Tissue-Derived Stem Cell Research 2019View this Special Issue
Research Article | Open Access
The Potential Role of Quorum Sensing in Clonal Growth and Subsequent Expansion of Bone Marrow Stromal Cell Strains in Culture
Clonal development (clonogenicity) is an inherent property of a subset of postnatal bone marrow (BM) adherent stromal mesenchymal stem cells (MSCs) from which a multipotent progeny develops in culture. Our data suggest that clonogenicity and BM-MSC expansion are two distinct biological events. This hypothesis is based on the following observations: (1) the beginning of clonal growth is a property strictly dependent on serum and independent of the social context, (2) the expansion of individual clone is influenced by events deriving from a social context during initial growth, (3) clonogenic cells grown in a social context in presence of serum can emancipate themselves to generate a secondary different progeny, and (4) the ability of socially generated clones to develop an inherent potential for further growth suggests that quorum sensing may operate in BM-MSC cultures and determine the potential growth of clonal strains.
In biology, quorum sensing (QS) is defined as a process by which cells are able to detect the accumulation of released signals and change their behavior when signal concentration exceeds threshold levels. QS in prokaryotes is based on the “communication between bacterial cells” necessary to organize and regulate internal biological processes within a cell, but that depends on population density . This mechanism allows in many bacteria species to coordinate behaviors in the entire population [2–4]. This interbacterial communication system utilizes small diffusible molecules (inducers) to regulate bacterial gene expression in accordance to population density. QS peptides are an important class of bacterial peptides having multiple effects on human host cells. Colonization of the large intestine in humans and cattle by enterohemorrhagic Escherichia coli involves cross-communication of biochemical signaling systems between bacterial pathogens and eukaryotic host cells [5–9].
Recently, it has been discovered that this mechanism is also able to influence mammalian host cells by promoting tumor cell invasion and angiogenesis in vitro, implying that QS are working via epigenetic mechanisms to stimulate cancer stem cell migration and normal stem cell differentiation for angiogenesis of vascular endothelial cells [10–13]. Previous studies demonstrated the existence of sophisticated mammalian cell-to-cell communications pathways regulating QS mechanisms for immune responses , including self/nonself T cell discrimination . This circuit of intercellular communication in mammalian cells coordinates multicellular gene expression [16, 17], and cytokines are good candidates as inducers of QS effects such as migration, proliferation, and differentiation [14, 18]. In this scenario, and in analogy with bacteria, we wanted to verify the existence of any QS behavior in initial clonal growth and subsequent expansion of mammalian postnatal marrow adherent stromal mesenchymal stem cells (MSCs) in culture.
Bone marrow (BM) stromal stem cells are cells residing in the medullary cavity of the bone . Also known as BM skeletal stem cells (BM-SSCs) or BM mesenchymal stem cells (BM-MSCs), they are specifically defined and identified only by in vivo transplantation assays [20, 21]. BM-MSCs are otherwise noted for the ability to initiate clonal growth (colony formation) and to generate an expanding, multipotent progeny in culture [20–22]. Thus, marrow stromal cell population contains precursor cells capable of proliferation, renewal, and differentiation into several phenotypes . Even after extended culture, marrow stromal mesenchymal cells can form bone, fibrous tissue, adipose tissue, and hematopoiesis-supporting reticular stroma [19, 23–28] when implanted in conventional in vivo differentiation assays. It is also known that Colony-Forming Unit Fibroblasts (CFU-Fs) derived from BM have osteogenic potential. Indeed, populations of marrow stromal skeletal CFU-Fs can differentiate into functional osteoblasts and form the bone in vivo [20, 21]. Strategies for cell therapy using MSCs are often based on common, unverified assumptions, without considering their specific biological properties, their commitment, or their in vitro biological behavior. This belief betrays and reflects our poor understanding of inherent cell properties, roles, and identity, ignoring all the environmental factors influencing or sometime determining MSC behavior, during their in vitro growth, and subsequently once transplanted in vivo.
2. Materials and Methods
2.1. Preparation of BM Single Cell Suspension and Culture
BM-MSCs were obtained from iliac crest marrow aspirates of adult healthy donors (age range 20-60 years). Human subjects provided us with oral assurance of their willingness to be enrolled in the research study. The overall study on human tissues was approved by the Research Ethics Committee of Istituto Superiore di Sanità of Rome (approval date September 20, 2016; Prot. PRE-686/16). BM aspirates (0.5-1 cm3) were mixed with 5 ml of ice-cold α-modified minimum essential medium (α-MEM, Life Technologies, NY, U.S.A.) containing 100 U/ml sodium heparin (Fisher Scientific, NJ, U.S.A.). Cells were centrifuged at 135g for 10 minutes, and pellets were resuspended in fresh α-MEM. Bone marrow cell preparations from aspirate were consecutively passed through 16 and 20 gauge needles to disrupt cell aggregates. Cell suspensions were filtered through a 40-nylon cell strainer (Becton Dickinson, San Diego, CA, USA) to remove any remaining cell aggregates. Cells were plated in standard condition basal medium α-MEM added with 20% Fetal Bovine Serum (FBS, Invitrogen, Carlsbad, CA, USA), 2 mM L-glutamine (Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin (Invitrogen, Carlsbad, CA, USA), and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) or with a serum-deprived medium (SDM) supplemented with 10 ng/ml Platelet-Derived Growth Factor (PDGF-BB, R&D systems, Minneapolis, MN, USA), 10 ng/ml Epidermal Growth Factor (EGF, R&D systems, Minneapolis, MN, USA), and fibronectin-coated substrates (Sigma-Aldrich, St. Louis, MO, USA).
2.2. Colony-Forming Efficiency (CFE) Assay
For multiclonal cultures, formed under “social conditions,” nucleated cells from fresh marrow aspirates were seeded into 100 mm dishes (Becton Dickinson Biosciences, San Diego, CA, USA) at a clonal density of nucleated cells/cm2  to assay for primary CFU-Fs. To assay for secondary CFU-Fs, adherent primary MSCs from BM-derived clonal cultures were seeded into 100 mm dishes at a clonal density of 1.6 cells/cm2. For single colonies formed under “isolation conditions,” cells were seeded in 96-well plates at limiting density. Formation of discrete colonies was scored after 14 days. After 14 days, the CFE was determined by counting the number of Giemsa-stained colonies: . Assays were done at least in triplicate. Individual colonies (clones) were isolated and expanded from multiclonal primary or secondary CFU-F cultures using cloning cylinders (Sigma-Aldrich, St. Louis, MO, USA). Alternately, multiclonal cultures were passaged on day 14.
2.3. Microscopy and Imaging of Cells in Culture
Samples of clonal nucleated cells from unsorted human BM were plated and cultured in 100 mm dishes ( cell/cm2). The lipophilic fluorescent carbocyanine cell tracking dye DiI-Ac-LDL (Invitrogen, Carlsbad, CA, USA) was used as per the manufacturer’s recommendations. Confocal fluorescence images-stacks of developmental stages of CFU-F from human BM stromal-labelled clonal cell to colony in culture were obtained using the Leica TCS SP5 confocal laser scanning microscopy system (Leica Microsystems, Mannheim, Germany) using the HeNe 543 nm and the Ar 488 nm laser lines for visualizing the red (DiI) or green (GFP) vital fluorochromes, respectively.
Time lapse brightfield light microscopy images of the development of an individual colony in human BM aspirate culture were obtained using a Zeiss Axiophot microscope (Carl Zeiss, Germany). Phase contrast images were acquired every 1-3 days.
2.4. Analysis of Cell Proliferation
For proliferation kinetics of MSCs, the cumulative population doubling (PD) levels were calculated from the cell count by the use of the following equation: , where cells are the number initially seeded and cells are the number harvested. The living cell count was performed in triplicate in a hemocytometer by means of trypan blue dye exclusion (Sigma-Aldrich, St. Louis, MO, USA).
2.5. Flow Cytometry
For fluorescence-activated cell sorting (FACS), cells from primary BM MSC-derived clone cultures were pelleted, resuspended in Ca2+Mg2+-free PBS and expression of markers was assessed using a FACSCalibur flow cytometer (Becton Dickinson Biosciences, San Diego, CA, USA). Data were analyzed with the use of Cell-Quest Pro software (version 6.1, Becton Dickinson Biosciences, San Diego, CA, USA).
Antibodies for flow cytometry are listed in Table 1.
MC: mouse monoclonal; FITC: fluorescein isothiocyanate; PE: phycoerythrin; APC: allophycocyanin.
2.7. Lentiviral Vectors
In some experiments, BM-MSCs from multiclonal cultures were transduced with green fluorescent protein (GFP)-lentiviral vectors. Lentiviral vectors for GFP expression were produced and used as described .
2.8. Statistical Analysis
Statistical analysis was performed by one-way ANOVA and subsequently by Bonferroni posttests. Results are expressed as (SD). Differences are considered statistically significant at .
3.1. Developmental Phases of an MSC Colony from a Single BM CFU-F
To investigate the development of early colonies, single DiI-labelled stromal BM-MSCs [days 1-15; Figure 1(a), A–C] from fresh unsorted marrow aspirates were seeded and cultured into 100 mm dishes at clonal density (total nucleated marrow cells/cm2) in standard condition and monitored by time-lapse microscopy. This analysis documented the existence of two distinct developmental phases of BM-MSC characterized in vitro. In the first phase, cell division and migration [days 1-7; Figure 1(b), A–H] defined boundaries and size of the forming colony. The second phase was characterized by stationary proliferation [days 7-15; Figure 1(b), H–J] leading first to increased cell density within colonies, then by filling-in space, to establish a territorially discrete, but internally continuous, monolayer [day 16; Figure 1(c)], to finally form a colony as we know it in culture dishes [Figure 1(d)].
3.2. Initial Clonal Growth Depends on Serum
To investigate clonal BM-MSC development, we prepared primary cultures from fresh unsorted marrow, seeding nucleated cells at a clonal density of cells/cm2 in a 100 mm Petri dish, either in standard conditions or in SDM. SDM is a medium able to ensure stromal strain proliferation at nonclonal densities, which can be obtained by seeding >105 total nucleated cells/cm2 from fresh marrow aspirates. Discrete colonies of >50 cells developed only in the presence of serum [Figures 2(a) and 2(b)]. In serum-free medium, cultured cells remained viable for 14 days but failed to generate colonies [Figures 2(c) and 2(d)].
3.3. Effect of Social Conditions on CFU-F Growth
To investigate BM-MSC clonogenic efficiencies, we prepared secondary cultures from primary BM-MSC cultures. We plated 100 secondary BM-MSCs at 1.6 cells/cm2 in a 100 mm Petri dish or at a limiting density in 96-well plates in standard conditions. Identical CFE [Figure 3(a), A–C] was observed when multiple clonogenic cells were plated in a single physical space compartment in a 100 mm Petri dish (“social conditions”) or when single clonogenic cells were seeded in a single physical space compartment at a limiting density in 96-well plates (≤1 cell in 1 space compartment; “isolation conditions”). This indicated that the capacity to initiate clonal growth is a context-independent property of a defined subset of BM-MSCs. Although no difference was observed in the number of colonies in the two types of culture, the total number of cells generated in social context cultures was more than 2-fold higher compared to that in cultures of cells generated at clonal density (data not shown). BM-MSC multicolonies from “social conditions” or “isolation conditions” exhibited a typical MSC phenotype [Figure 3(b), A and B], as defined by the International Society for Cellular Therapy (ISCT) , being strongly positive for CD73, CD90, and CD105 and negative for the hematopoietic markers CD34 and CD45. The flow cytometry analysis of immune-related markers confirmed the constitutive expression of HLA-A, HLA-B, and HLA-C antigens and the absence of HLA-DR [Figure 3(b), A and B].
3.4. Clonal Expansion Is a Biological Property of MSC Acquired in a Social Context
To investigate expansion abilities of BM MSC-initiated clones, we prepared secondary cultures from primary BM-MSC cultures. We plated 100 secondary BM-MSCs at 1.6 cells/cm2 in a 100 mm Petri dish or at a limiting density in 96-well plates in standard conditions. Samples from the same parent culture formed the same number of colonies under “social” [Figure 4(a), A] and “isolation” conditions [Figure 4(a), C]. However, when we monitored the ability of individual clones generated either in “isolation” or under “social” conditions to grow and expand, only the colonies exposed to “social conditions” during the initial phase of clonal expansion were able to preserve a potential for further growth [Figure 4(a), B and D]. Continuous passaging of individual colonies revealed dramatic differences of expansion capabilities between clones initially seeded under “social” or “isolation” conditions [Figure 4(a), A–D]. In particular, colonies formed under “social conditions” could be further expanded [up to 22-24 PD; Figure 4(b)], while colonies formed in 96 wells underwent senescence after few duplications [up to 22-26 PD; Figure 4(b)] and [14-17 PD; Figures 4(b) and 4(c)].
3.5. Promiscuity Rescues Proliferation of Growth-Impaired MSC Clones
To further investigate the roles of initial social deprivation in limiting subsequent clonal expansion of individual clonogenic cells, we assessed whether expansion capabilities of clones initially grown in isolation could be rescued by exposing them to a promiscuous environment. To address this question, 5 clones were grown in isolation [Figure 5(a), A] in 96-well plates to subconfluency, trypsinized, and split in two halves [Figure 5(a), B]. From each clone, one half was replated in 6-well plates as a single clone [Figure 5(a), C]; the other half was pooled with all other half clones [Figure 5(a), D]. The pool was subdivided into 5 samples, each containing the same number of cells as each pure clonal strain and replated in 6-well plates. In this way, cells from growth impaired clones could be either exposed or not, to the influence of cellular promiscuity. Pure half colonies underwent senescence after 5 PD, whereas the expansion of mixed strains, including the same number of cells as pure half colonies, continued for >10 PD [Figure 5(a), E–G].
Next, 100 cell samples of primary BM-derived clone cultures stably transduced with GFP-lentiviral vectors were plated in 100 mm dishes (1.6 cells/cm2), either alone or together with 100 untagged GFP BM-MSCs [“mixed culture”; Figure 5(b), A and B]. Identical numbers of GFP+ colonies formed in either type of cultures were generated 14 days later. Although no differences were observed examining the number of GFP+ colonies in the two types of culture, the total number of GFP+ cells generated in mixed cultures was more than 2-fold higher as compared to that in BM-MSC cultures plated alone at clonal density; this indicates that the magnitude of initial clonal growth of individual clonogenic cells is influenced by the total number of cells initially present in culture [Figure 5(b), C and D]. These experiments showed that promiscuous strains resumed the ability for efficient expansion, whereas pure clonal strains remained growth impaired.
The term “quorum sensing” is derived from Latin quorum; in politics, this is the number of votes that must be cast for an election or referendum to be valid. In biology, QS is defined as a process by which cells detect the accumulation of released signals and then change their behavior when signal concentration exceeds a threshold level. Cells communicate using chemical signaling molecules. Information provided by these molecules is critical for synchronizing activities of large groups of cells . This chemical communication allows cells to monitor their environment and change behavior accordingly. This network of cell-cell cross-communication is integrated by cells, processed, and transduced to control gene expression. Identification of these chemical signals, receptors, target genes, and mechanisms of signal transduction involved in the QS network may help to shed light on cell-cell communication. This can be seen as a chemical vocabulary, and signaling networks are complex and often consist of multiple circuits organized in a variety of configurations, still to be identified. All these factors modulate mammalian cell behavior promoting development and differentiation and should be considered in future applications [16, 17]. QS is a system of stimuli/responses correlated to population density. However, QS is also activated by a single cell when seeded in an extremely enclosed space. Indeed, QS-regulated processes are relevant for both large cell colonies and single cells in confined spaces. Mechanisms of stem cell self-renewal are crucial to stem cell biology and regenerative medicine.
Historically, the very first evidence indicating the existence of stem cell postnatal progenitors for connective tissues originated from the seminal work of Friedenstein and coworkers, who were able to demonstrate that inherent osteogenic, adipogenic, and chondrogenic potential of unfractionated BM, known from earlier studies, could be ascribed to (a) a nonhematopoietic, stromal fraction and (b) single cells, capable of initiating clonal growth in a density-insensitive fashion [30–32]. The studies proposed here are not aimed at investigating niche-dependent and population-dependent mechanisms of MSC regulation but only at developing a series of hypotheses based on our observations. With these premises, we asked if there is any QS rule in clonogenicity and secondary expansion of BM-derived stromal MSCs.
Using a combination of time-lapse microscopy, permutation of culture conditions, and labeling methods, we observed that distinct seeding setup could affect biological properties including clonogenicity and secondary expansion of BM-derived mesenchymal stromal cells. Indeed, we observed that initiation of clonal growth and subsequent in vitro expansion of BM-MSC clonal stromal cell strains are biologically distinct events. Two developmental stages were recognized during the growth of each colony. In the first phase, lasting for the first week after plating, cells proliferate and migrate to define the area of the substrate to be covered by the monolayer (definition of territory). In the second phase, cells proliferate inside the previously marked territory, to generate a typical colony (filling up phase). However, clonogenicity of this subset of stromal adherent cells is strictly dependent on serum and independent of the social context. In contrast, clonogenicity is not supported by a serum-free medium. Further expansion of individual clones is affected by events emanating from a social context during initial growth. The ability of socially generated clones to develop an inherent potential for further growth suggests that effects of the quorum rule may operate in BM-MSC cultures and determine potential growth of clonal strains derived from single BM-CFU-F-MSCs. Acceptance of this paradigm identified for stromal BM-MSC biology might in general be useful to regulate BM-MSC expansion for clinical applications of skeletal regenerative therapies.
Our observations led us to hypothesize that some biological properties of clonal MSCs such as generation of discrete colonies and their expansion to larger single colony-derived population are differentially regulated. In the presence of serum, single clonal MSCs are able to generate discrete colonies independently of plating conditions. However, the capability to generate a larger pure clonal cell population seems to depend on reciprocal influences among different stromal cells. The influence of the social context is effective at the early stages of colony development, during which clonal cells commit to a potential larger expansion over time. Therefore, in analogy with bacterial biofilm, MSC populations can be considered “multicellular communities” providing single cells with distinct biological properties. The aim of this study was to evaluate the ex vivo amplification potential of BM-derived MSCs using defined culture conditions as growth stimulus. These data will be beneficial to set standards for tissue collection and MSC clinical-scale expansion, both for cell banking and for cell-based therapy settings. Studies on the QS cell-to-cell communication network system of ex vivo BM stromal MSC biological properties from functional commitment to growth abilities should be further explored, in perspective of refined clinical use for new therapeutic strategies.
All relevant data used to support the findings of this study are included within the paper.
Conflicts of Interest
All authors state that they have no competing financial interests.
Benedetto Sacchetti is responsible for the conceptualization, data curation, investigation, and supervision. Maurizio Alimandi, Luca Pierelli, Stefano Gentileschi, and Benedetto Sacchetti are assigned to the validation. Maurizio Alimandi, Luca Pierelli, and Benedetto Sacchetti are responsible for the writing and original draft. Maurizio Alimandi, Luca Pierelli, Valentina Pino, Stefano Gentileschi, and Benedetto Sacchetti are responsible for the writing, reviewing, and editing. Maurizio Alimandi and Luca Pierelli contributed equally to this work.
This work has been financially supported by Genostem (LHSB-CT-2003-503161) (to P.B.). We acknowledge the contribution of Prof. Paolo Bianco (Sapienza University, Rome), recently deceased, for all of his insights and contributions over the years, providing the basis for this study. We are grateful to Desiree Bonci for her contribution in GFP-lentiviral transduction of human BM stromal-MSCs.
- J. Q. Boedicker, M. E. Vincent, and R. F. Ismagilov, “Microfluidic confinement of single cells of bacteria in small volumes initiates high-density behavior of quorum sensing and growth and reveals its variability,” Angewandte Chemie International Edition, vol. 48, no. 32, pp. 5908–5911, 2009.
- M. Schuster and E. Peter Greenberg, “A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa,” International Journal of Medical Microbiology, vol. 296, no. 2-3, pp. 73–81, 2006.
- C. A. Martin, A. D. Hoven, and A. M. Cook, “Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum-sensing,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 27, no. 8, pp. 635–642, 2008.
- S. P. Diggle, S. A. Crusz, and M. Cámara, “Quorum sensing,” Current Biology, vol. 17, no. 21, pp. R907–R910, 2007.
- S. Atkinson and P. Williams, “Quorum sensing and social networking in the microbial world,” Journal of the Royal Society Interface, vol. 6, no. 40, pp. 959–978, 2009.
- D. T. Hughes, D. A. Terekhova, L. Liou et al., “Chemical sensing in mammalian host–bacterial commensal associations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 21, pp. 9831–9836, 2010.
- I. Sekirov, S. L. Russell, L. C. M. Antunes, and B. B. Finlay, “Gut microbiota in health and disease,” Physiological Reviews, vol. 90, no. 3, pp. 859–904, 2010.
- L. Dethlefsen, M. McFall-Ngai, and D. A. Relman, “An ecological and evolutionary perspective on human–microbe mutualism and disease,” Nature, vol. 449, no. 7164, pp. 811–818, 2007.
- N. King, “Nature and nurture in the evolution of cell biology,” Molecular Biology of the Cell, vol. 21, no. 22, pp. 3801-3802, 2010.
- E. Wynendaele, E. Pauwels, C. van de Wiele, C. Burvenich, and B. de Spiegeleer, “The potential role of quorum-sensing peptides in oncology,” Medical Hypotheses, vol. 78, no. 6, pp. 814–817, 2012.
- E. Wynendaele, F. Verbeke, M. D’Hondt et al., “Crosstalk between the microbiome and cancer cells by quorum sensing peptides,” Peptides, vol. 64, pp. 40–48, 2015.
- B. De Spiegeleer, F. Verbeke, M. D’Hondt et al., “The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro,” PLoS One, vol. 10, no. 3, article e0119471, 2015.
- Y. Janssens, E. Wynendaele, F. Verbeke et al., “Screening of quorum sensing peptides for biological effects in neuronal cells,” Peptides, vol. 101, pp. 150–156, 2018.
- L. Perié, J. Aru, P. Kourilsky, and J. J. Slotine, “Does a quorum sensing mechanism direct the behavior of immune cells?” Comptes Rendus Biologies, vol. 336, no. 1, pp. 13–16, 2013.
- T. C. Butler, M. Kardar, and A. K. Chakraborty, “Quorum sensing allows T cells to discriminate between self and nonself,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 29, pp. 11833–11838, 2013.
- W. D. Wang, Z. T. Chen, B. G. Kang, and R. Li, “Construction of an artificial intercellular communication network using the nitric oxide signaling elements in mammalian cells,” Experimental Cell Research, vol. 314, no. 4, pp. 699–706, 2008.
- S. Tao, L. Niu, L. Cai et al., “N-(3-Oxododecanoyl)-l-homoserine lactone modulates mitochondrial function and suppresses proliferation in intestinal goblet cells,” Life Sciences, vol. 201, pp. 81–88, 2018.
- I. S. Mian and C. Rose, “Communication theory and multicellular biology,” Integrative Biology, vol. 3, no. 4, pp. 350–367, 2011.
- M. Owen, “Marrow stromal stem cells,” Journal of Cell Science, vol. 1988, Supplement 10, pp. 63–76, 1988.
- S. A. Kuznetsov, P. H. Krebsbach, K. Satomura et al., “Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo,” Journal of Bone and Mineral Research, vol. 12, no. 9, pp. 1335–1347, 1997.
- B. Sacchetti, A. Funari, S. Michienzi et al., “Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment,” Cell, vol. 131, no. 2, pp. 324–336, 2007.
- M. Dominici, K. le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
- H. Castro-Malaspina, R. E. Gay, G. Resnick et al., “Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny,” Blood, vol. 56, no. 2, pp. 289–301, 1980.
- Z. X. Song and P. J. Quesenberry, “Radioresistant murine marrow stromal cells: a morphologic and functional characterization,” Experimental Hematology, vol. 12, no. 7, pp. 523–533, 1984.
- R. G. Fei, P. E. Penn, and N. S. Wolf, “A method to establish pure fibroblast and endothelial cell colony cultures from murine bone marrow,” Experimental Hematology, vol. 18, no. 8, pp. 953–957, 1990.
- R. W. Zhang, S. C. Supowit, X. Xu et al., “Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma,” Calcified Tissue International, vol. 56, no. 4, pp. 283–291, 1995.
- B. A. Ashton, T. D. Allen, C. R. Howlett, C. C. Eaglesom, A. Hattori, and M. Owen, “Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo,” Clinical Orthopaedics and Related Research, vol. 151, pp. 294–307, 1980.
- J. H. Bennett, C. J. Joyner, J. T. Triffitt, and M. E. Owen, “Adipocytic cells cultured from marrow have osteogenic potential,” Journal of Cell Science, vol. 99, pp. 131–139, 1991.
- D. Bonci, A. Cittadini, M. V. G. Latronico et al., “Advanced’ generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo,” Gene Therapy, vol. 10, no. 8, pp. 630–636, 2003.
- A. J. Friedenstein, “Osteogenic stem cells in bone marrow,” in Bone and Mineral Research, J. N. M. Heersche and J. A. Kanis, Eds., pp. 243–272, Elsevier, Amsterdam, The Netherlands, 1990.
- A. J. Friedenstein, I. I. Piatetzky-Shapiro, and K. V. Petrakova, “Osteogenesis in transplants of bone marrow cells,” Journal of Embryology and Experimental Morphology, vol. 16, no. 3, pp. 381–390, 1966.
- A. J. Friedenstein, K. V. Petrakova, A. I. Kurolesova, and G. P. Frolova, “Heterotopic transplants of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues,” Transplantation, vol. 6, no. 2, pp. 230–247, 1968.
Copyright © 2019 Maurizio Alimandi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.